<DOC>
	<DOCNO>NCT00753493</DOCNO>
	<brief_summary>The aim study determine , adult patient maintenance topiramate therapy , steady-state pharmacokinetics safety orally intravenously administer topiramate .</brief_summary>
	<brief_title>Pharmacokinetics Safety Intravenous Topiramate Adult Patients</brief_title>
	<detailed_description>The long-term goal research project develop effective , safe therapy neonatal seizure . Prior use investigational intravenous topiramate formulation child neonate , pharmacokinetics safety formulation must demonstrate adult . The immediate aim study determine pharmacokinetics safety novel intravenous topiramate formulation . An additional aim determine sex , advance age , genotype affect topiramate absorption , distribution , elimination .</detailed_description>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Persons take topiramate Persons 18 year age old Patients pregnant Patients breast feed Patients significant medical problem may tolerate intravenous administration Patients take medication know affect topiramate disposition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>